# PTGX (Protagonist Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Protagonist Therapeutics, Inc. reported $551.7M in revenue and net income of $342.3M for the trailing twelve months ended September 30, 2026 (up 5723.6% year over year), with a 58.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/PTGX
- Markdown: https://convexityos.com/fundamentals/PTGX.md
- SEC CIK: 0001377121
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001377121&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $551.7M | +5723.6% YoY |
| Operating Income | TTM | $323.1M | 58.6% margin |
| Net Income | TTM | $342.3M | 62.0% net margin |
| Diluted EPS | TTM | $4.77 | Split-adjusted |
| Free Cash Flow | TTM | $109.1M | 19.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $800.1M | Total debt: $8.63M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $46.02M | $434.4M | $60.00M | $26.58M | $27.36M | $28.63M | $231K | $30.93M | $20.06M | -- |
| Research & Development | $159.3M | $138.1M | $120.2M | $126.2M | $126.0M | $74.51M | $65.00M | $59.50M | $46.18M | $25.70M |
| Total Operating Expenses | $204.1M | $181.6M | $153.7M | $158.0M | $153.2M | $93.14M | $80.75M | $73.19M | $57.96M | $32.67M |
| **Operating Income** | -$158.1M | $252.8M | -$93.65M | -$131.4M | -$125.8M | -$64.52M | -$80.52M | -$42.27M | -$37.90M | -$32.67M |
| **EBITDA** | -$156.8M | $253.7M | -$92.67M | -$130.3M | -$125.0M | -$63.57M | -$79.79M | -$41.74M | -$37.49M | -$32.35M |
| Interest Income | $28.79M | $26.32M | $14.90M | $4.06M | $443K | $900K | $2.81M | $2.57M | $948K | $242K |
| Interest Expense | -- | -- | -- | -- | -- | $598K | $169K | -- | -- | -- |
| Income Before Tax | -$129.3M | $279.4M | -$78.95M | -$127.4M | -$125.6M | -$64.84M | -$77.88M | -$39.72M | -$36.96M | -$37.18M |
| Income Tax Expense | $838K | $4.22M | $0 | $0 | $0 | $1.30M | -$691K | -$799K | $0 | $0 |
| **Net Income** | -$130.1M | $275.2M | -$78.95M | -$127.4M | -$125.6M | -$66.15M | -$77.19M | -$38.92M | -$36.96M | -$37.18M |
| Basic EPS | -$2.05 | $4.47 | -$1.39 | -$2.60 | -$2.71 | -$1.92 | -$2.98 | -$1.74 | -$2.09 | -$5.80 |
| **Diluted EPS** | -$2.05 | $4.23 | -$1.39 | -$2.60 | -$2.71 | -$1.92 | -$2.98 | -$1.74 | -$2.09 | -$5.80 |
| Basic Shares Outstanding | 63.6M | 61.6M | 56.8M | 49.0M | 46.3M | 34.4M | 25.9M | 22.4M | 17.7M | 6.5M |
| Diluted Shares Outstanding | 63.6M | 65.1M | 56.8M | 49.0M | 46.3M | 34.4M | 25.9M | 22.4M | 17.7M | 6.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $274.4M | $213.5M | $56.37M | $7.44M | $4.71M | $5.55M | $28.32M | $170.6M |
| Cost of Revenue | $1.10M | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $273.3M | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $41.27M | $42.06M | $46.74M | $46.36M | $40.00M | $37.04M | $35.89M | $34.90M |
| Total Operating Expenses | -- | $54.71M | $60.02M | $57.79M | $51.13M | $47.59M | $47.63M | $43.86M |
| **Operating Income** | $218.3M | $158.8M | -$3.65M | -$50.35M | -$46.42M | -$42.04M | -$19.31M | $126.8M |
| **EBITDA** | $218.7M | $159.2M | -$3.24M | -$49.98M | -$46.06M | -$41.74M | -$19.07M | $126.9M |
| Interest Income | $8.25M | $6.43M | $5.88M | $6.76M | $7.05M | $7.41M | $7.57M | $6.85M |
| Income Before Tax | $226.6M | $165.1M | $2.28M | -$43.72M | -$39.34M | -$34.60M | -$11.65M | $133.7M |
| Income Tax Expense | $6.56M | $2.27M | -$1.50M | $666K | $0 | $172K | $0 | $1.99M |
| **Net Income** | $220.0M | $162.8M | $3.78M | -$44.38M | -$39.34M | -$34.77M | -$11.65M | $131.7M |
| Basic EPS | $3.32 | $2.47 | $0.06 | -- | -$0.62 | -$0.55 | -$0.19 | -- |
| **Diluted EPS** | $3.07 | $2.29 | $0.05 | -- | -$0.62 | -$0.55 | -$0.19 | -- |
| Basic Shares Outstanding | 66.4M | 65.9M | 65.1M | -- | 63.8M | 63.5M | 63.0M | -- |
| Diluted Shares Outstanding | 71.7M | 71.0M | 70.5M | -- | 63.8M | 63.5M | 63.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $128.4M | $97.25M | $186.7M | $125.7M | $123.7M | $117.4M | $33.01M | $82.23M | $106.0M | $21.08M |
| Short-Term Investments | $439.0M | $321.7M | $154.9M | $111.6M | $203.2M | $188.5M | $100.0M | $46.62M | -- | -- |
| **Cash & Short-Term Investments** | $567.4M | $418.9M | $341.6M | $237.4M | $326.9M | $305.8M | $133.0M | $128.9M | $106.0M | $21.08M |
| Other Current Assets | $10K | $248K | $76K | $42K | -- | -- | -- | -- | $1.07M | $498K |
| **Total Current Assets** | $577.6M | $591.6M | $355.6M | $243.1M | $340.7M | $315.6M | $145.3M | $137.5M | $150.9M | $83.24M |
| Property, Plant & Equipment, Net | $3.86M | $3.19M | $1.20M | $1.56M | $1.80M | $1.46M | $1.68M | $861K | $879K | $562K |
| Long-Term Investments | $78.64M | $140.3M | -- | $0 | -- | $2.00M | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $34K |
| **Total Non-Current Assets** | $90.61M | $153.1M | $2.37M | $4.85M | $6.96M | $8.86M | $9.61M | $1.97M | $12.79M | $10.75M |
| **Total Assets** | $668.2M | $744.7M | $358.0M | $247.9M | $347.7M | $324.5M | $154.9M | $139.5M | $163.7M | $93.99M |
| Accounts Payable | $5.34M | $1.61M | $772K | $3.64M | $1.60M | $3.08M | $2.79M | $5.71M | $1.26M | $1.16M |
| Deferred Revenue (Current) | -- | -- | $3.0K | $69K | $899K | $14.48M | $17.74M | $8.22M | $31.75M | -- |
| **Total Current Liabilities** | $45.44M | $47.40M | $21.27M | $31.18M | $44.02M | $40.24M | $35.41M | $26.16M | $42.55M | $6.43M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $9.79M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $11.68M | -- | -- | -- | -- | $23.79M | -- | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $121K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $8.04M | $22.03M | $0 | $1.14M | $3.66M | $4.62M | $39.55M | $799K | $547K | $0 |
| **Total Liabilities** | $53.48M | $69.43M | $21.27M | $32.32M | $47.67M | $44.86M | $74.95M | $26.96M | $43.10M | $6.43M |
| **Total Debt (incl. Leases)** | $10.32M | $10.87M | $1.14M | $3.66M | $5.86M | $5.96M | $17.01M | -- | -- | -- |
| Common Stock | $1.0K | $1.0K | $1.0K | -- | -- | -- | -- | $0 | $0 | $0 |
| Retained Earnings | -$470.7M | -$340.5M | -$615.7M | -$536.8M | -$409.4M | -$283.8M | -$217.7M | -$140.5M | -$101.5M | -$64.59M |
| Accumulated Other Comp. Income | $641K | -$82K | -$105K | -$359K | -$299K | $28K | -$221K | -$233K | -$6.0K | -$245K |
| **Total Stockholders' Equity** | $614.7M | $675.3M | $336.7M | $215.6M | $300.0M | $279.6M | $79.96M | $112.5M | $120.6M | $87.56M |
| Total Equity | $614.7M | $675.3M | $336.7M | $215.6M | $300.0M | $279.6M | $79.96M | $112.5M | $120.6M | $87.56M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $498.3M | $420.1M | $193.7M | $128.4M | $113.7M | $168.5M | $139.7M | $97.25M |
| Short-Term Investments | $301.8M | $362.5M | $354.1M | $439.0M | $462.4M | $401.9M | $434.7M | $321.7M |
| **Cash & Short-Term Investments** | $800.1M | $782.6M | $547.8M | $567.4M | $576.1M | $570.5M | $574.4M | $418.9M |
| Other Current Assets | -- | -- | -- | $10K | $191K | $92K | -- | $248K |
| **Total Current Assets** | $1.10B | $807.1M | $613.5M | $577.6M | $586.4M | $602.5M | $605.9M | $591.6M |
| Property, Plant & Equipment, Net | $3.32M | $3.46M | $3.78M | $3.86M | $4.10M | $4.11M | $3.53M | $3.19M |
| Long-Term Investments | $34.56M | $66.88M | $72.55M | $78.64M | $102.7M | $102.5M | $123.5M | $140.3M |
| Other Non-Current Assets | $832K | $832K | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $45.49M | $78.40M | $84.00M | $90.61M | $115.3M | $115.5M | $136.3M | $153.1M |
| **Total Assets** | $1.15B | $885.5M | $697.5M | $668.2M | $701.7M | $718.0M | $742.1M | $744.7M |
| Accounts Payable | $5.92M | $3.46M | $8.44M | $5.34M | $5.65M | $3.25M | $2.92M | $1.61M |
| **Total Current Liabilities** | $55.46M | $37.18M | $34.55M | $45.44M | $44.94M | $35.51M | $35.11M | $47.40M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $2.79M | $5.38M | $8.18M | $11.68M |
| **Total Non-Current Liabilities** | $6.18M | $6.82M | $7.44M | $8.04M | $11.31M | $14.48M | $17.97M | $22.03M |
| **Total Liabilities** | $61.64M | $44.00M | $41.99M | $53.48M | $56.25M | $49.99M | $53.08M | $69.43M |
| **Total Debt (incl. Leases)** | $8.63M | $9.22M | $9.78M | $10.32M | $10.75M | $11.28M | $11.36M | $10.87M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$84.02M | -$304.0M | -$466.9M | -$470.7M | -$426.3M | -$386.9M | -$352.2M | -$340.5M |
| Accumulated Other Comp. Income | -$1.29M | -$828K | -$269K | $641K | $525K | -$15K | $85K | -$82K |
| **Total Stockholders' Equity** | $1.08B | $841.5M | $655.5M | $614.7M | $645.4M | $668.0M | $689.1M | $675.3M |
| Total Equity | $1.08B | $841.5M | $655.5M | $614.7M | $645.4M | $668.0M | $689.1M | $675.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$130.1M | $275.2M | -$78.95M | -$127.4M | -$125.6M | -$66.15M | -$77.19M | -$38.92M | -$36.96M | -$37.18M |
| Depreciation & Amortization | $1.28M | $826K | $977K | $1.03M | $813K | $948K | $732K | $527K | $406K | $317K |
| Stock-Based Compensation | $45.97M | $37.55M | $29.29M | $24.20M | $16.39M | $7.90M | $8.35M | $6.92M | $4.24M | $2.13M |
| Change in Payables | $3.72M | $842K | -$2.87M | $2.04M | -$1.39M | $309K | -$3.00M | $4.43M | $91K | -$115K |
| **Operating Cash Flow** | $57.67M | $184.2M | -$70.24M | -$108.1M | -$107.9M | -$72.48M | -$41.53M | -$49.95M | $3.87M | -$29.97M |
| Capital Expenditure | -$1.59M | -$1.35M | -$609K | -$795K | -$1.10M | -$471K | -$967K | -$486K | -$666K | -$347K |
| **Free Cash Flow** | $56.08M | $182.8M | -$70.84M | -$108.9M | -$109.0M | -$72.95M | -$42.49M | -$50.43M | $3.21M | -$30.32M |
| Purchases of Investments | -$546.6M | -$621.7M | -$191.0M | -$214.9M | -$286.6M | -$280.0M | -$166.9M | -$71.06M | -$39.55M | -- |
| **Investing Cash Flow** | -$49.33M | -$299.5M | -$39.26M | $91.47M | -$15.86M | -$90.97M | -$53.71M | $2.21M | $15.82M | -$59.33M |
| Common Stock Issued | -- | -- | $107.8M | -- | $123.8M | $213.3M | $34.49M | $1.51M | -- | -- |
| **Financing Cash Flow** | $22.86M | $25.85M | $170.5M | $18.84M | $129.9M | $247.6M | $46.04M | $24.11M | $65.55M | $106.3M |
| **Net Change in Cash** | $31.20M | -$89.48M | $60.98M | $2.08M | $6.07M | $84.35M | -$49.23M | -$23.80M | $85.39M | $17.03M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $220.0M | $162.8M | $3.78M | -$44.38M | -$39.34M | -$34.77M | -$11.65M | $131.7M |
| Depreciation & Amortization | $409K | $397K | $407K | $376K | $361K | $304K | $239K | $118K |
| Stock-Based Compensation | $14.36M | $14.04M | $14.52M | $10.70M | $10.56M | $10.91M | $13.80M | $9.09M |
| Change in Payables | $2.46M | -$4.90M | $3.00M | -$307K | $2.42M | $375K | $1.24M | -$1.43M |
| **Operating Cash Flow** | -$23.22M | $219.1M | -$48.94M | -$36.98M | -$1.94M | -$28.78M | $125.4M | -$29.18M |
| Capital Expenditure | -$237K | -$168K | -$215K | -$144K | -$88K | -$813K | -$545K | -$310K |
| **Free Cash Flow** | -$23.46M | $218.9M | -$49.16M | -$37.12M | -$2.02M | -$29.59M | $124.8M | -$29.49M |
| Purchases of Investments | -$8.95M | -$134.7M | -$68.97M | -$104.3M | -$161.1M | -$67.15M | -$214.0M | -$114.4M |
| **Investing Cash Flow** | $93.43M | -$2.43M | $90.89M | $48.81M | -$58.55M | $54.81M | -$94.40M | -$8.72M |
| **Financing Cash Flow** | $8.01M | $9.74M | $23.37M | $2.84M | $5.66M | $2.92M | $11.44M | $4.03M |
| **Net Change in Cash** | $78.22M | $226.4M | $65.32M | $14.68M | -$54.83M | $28.95M | $42.40M | -$33.87M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% | -225.4% | -34857.6% | -136.7% | -188.9% | -- |
| **Net Profit Margin** | -282.8% | 63.3% | -131.6% | -479.3% | -458.9% | -231.1% | -33414.3% | -125.9% | -184.2% | -- |
| Return on Equity (ROE) | -21.2% | 40.8% | -23.5% | -59.1% | -41.8% | -23.7% | -96.5% | -34.6% | -30.6% | -42.5% |
| Return on Assets (ROA) | -19.5% | 37.0% | -22.1% | -51.4% | -36.1% | -20.4% | -49.8% | -27.9% | -22.6% | -39.6% |
| Current Ratio | 12.71x | 12.48x | 16.71x | 7.80x | 7.74x | 7.84x | 4.10x | 5.26x | 3.55x | 12.94x |
| Quick Ratio | 12.49x | 8.84x | 16.06x | 7.61x | 7.43x | 7.60x | 3.76x | 4.93x | 2.49x | 3.28x |
| Debt to Equity | 0.02x | 0.02x | 0.00x | 0.02x | 0.02x | 0.02x | 0.21x | -- | -- | -- |
| **Revenue Growth (YoY)** | -89.4% | +624.1% | +125.7% | -2.8% | -4.4% | +12293.1% | -99.3% | +54.1% | -- | -- |
| Operating Income Growth (YoY) | -162.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -147.3% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -145.9% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -68.7% | -- | -- | -- | -- | -- | -- | -1390.0% | -- | -- |
| Free Cash Flow Growth (YoY) | -69.3% | -- | -- | -- | -- | -- | -- | -1673.1% | -- | -- |
| 5Y Revenue / Share Growth | -13.0% | +78997.4% | -23.6% | -52.2% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 58.6% | 20.7% | -192.4% | -343.6% | 9.1% | 11.5% | 13.1% | 58.2% |
| **Net Profit Margin** | 62.0% | 29.4% | -154.9% | -282.8% | 21.9% | 24.9% | 27.0% | 63.3% |
| Return on Equity (ROE) | 31.5% | 9.9% | -17.5% | -21.2% | 7.1% | 7.8% | 8.2% | 40.8% |
| Return on Assets (ROA) | 29.9% | 9.4% | -16.4% | -19.5% | 6.5% | 7.2% | 7.6% | 37.0% |
| Current Ratio | 19.85x | 21.71x | 17.76x | 12.71x | 13.05x | 16.97x | 17.26x | 12.48x |
| Quick Ratio | 14.42x | 21.05x | 15.86x | 12.49x | 12.82x | 16.07x | 16.36x | 8.84x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |
| **Revenue Growth (YoY)** | +5723.6% | +3749.2% | +99.0% | -95.6% | +0.8% | +33.1% | -88.9% | +184.4% |
| Operating Income Growth (YoY) | -- | -- | -- | -139.7% | -- | -- | -109.4% | +450.0% |
| **Net Income Growth (YoY)** | -- | -- | -- | -133.7% | -- | -- | -105.6% | +381.7% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -105.6% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -139.0% | -- | -- | -110.7% | -- | -272.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -139.4% | -- | -- | -111.0% | -- | -274.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
